1. Scrip

Coronavirus Update: Pfizer Vaccine Candidates Gain Fast-Track Status

Two mRNA Candidates Selected

 
• By Scrip Team

The granting of fast-track status is a clear signal that the US FDA wants to maintain its high standards of drug and vaccine appraisal.

Face covering
Face coverings will be mandatory in England's shops from 24 July, bringing it into line with Scotland and other European nations such as Spain, Italy and Germany.

Two of the four investigational COVID-19 vaccine candidates being developed by Pfizer Inc. and BioNTech have gained fast track designation from the US Food and Drug Administration.

The two candidates using the mRNA-based vaccine platform are BNT162b1 and BNT162b2 and are the most advanced in the partners’ ongoing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.

Executives On The Move: Pathos Procures CEO From AstraZeneca, New CEO For TME Pharma, And More

Recent moves in the industry include changes at the top at Akamis Bio, Innospera Pharma & Ispen, plus Astellas Korea appoints an ex-Novartis Korea executive.